Recursion Pharmaceuticals, Inc.
RXRXNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $1.97B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.77$6.70
- Volume (live)
- -
- Avg. volume (3M)
- 29.01M
Recursion Pharmaceuticals (RXRX) Stock Price & Financial Analysis
Recursion Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.45 - $3.70 |
|---|---|
| 52-Week High | $6.70 |
| 52-Week Low | $2.77 |
| Open | $3.52 |
| Volume (last close) | 19.08M |
| Average Volume (3M) | 29.01M |
| Revenue (TTM) | 54.85M |
|---|---|
| Net Income (TTM) | -518.89M |
| Free Cash Flow (TTM) | -354.19M |
| EPS (TTM) | −$1.02 |
| Profit Margin | -945.92% |
| Operating Margin | -991.72% |
| Return on Equity (ROE) | -56.71% |
| Debt to Equity | 0.02 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 1.97B |
|---|---|
| Shares Outstanding | 532.46M |
| Price to Sales (P/S) | 35.91 |
| Price to Book (P/B) | 2.15 |
| EV/EBITDA | -3.00 |
| 50-Day MA | $3.64 |
|---|---|
| 200-Day MA | $3.56 |
| 1-Year Change | −37.52% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Recursion Pharmaceuticals at a Glance
As of the Oct 23, 2026 close, Recursion Pharmaceuticals (RXRX) has a market capitalization of $1.97B. The stock trades at 35.9× sales. Over the trailing twelve months it lost $518.89M on revenue of $54.85M and burned $354.19M of free cash flow. Revenue fell 15.1% year over year.
As of its latest reported balance sheet, it holds $545.68M in cash and securities against $14.20M of debt, a net cash position of $531.49M.
Recursion Pharmaceuticals does not currently pay a dividend.
The share price is down 37.5% over the past year. At $3.70 (the Oct 23, 2026 close) it sits within its 52-week range of $2.77 to $6.70, above its 200-day moving average of $3.56.
Based on 8 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $6.63, 79.2% above the Oct 23, 2026 close.
Frequently Asked Questions About Recursion Pharmaceuticals
What is the current stock price for RXRX?
As of the Oct 23, 2026 close, RXRX stock trades at $3.70. The 52-week range is $2.77–$6.70, with a day range of $3.45–$3.70.
What is the P/E ratio for RXRX?
The P/E ratio (Price-to-Earnings) for RXRX is shown in the Key Statistics section. This valuation metric helps compare Recursion Pharmaceuticals, Inc. to industry peers.
Does RXRX pay dividends?
Recursion Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for RXRX?
Based on ratings from 8 professional analysts over the last 90 days, the consensus for RXRX is Hold. The average 12-month price target is $6.63, a 79.2% upside from the Oct 23, 2026 close of $3.70.
What is the market cap of RXRX?
As of the Oct 23, 2026 close, Recursion Pharmaceuticals's market capitalization is $1.97B, classifying it as a small-cap company. Recursion Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.